Can Als Disease Be Cured? | Realistic Treatment Outcomes

There’s no cure yet, but approved medicines and proactive care can slow decline and help many people live longer with better day-to-day function.

A “cure” would mean the disease stops and lost motor-neuron function returns. That isn’t available today. What is available is a set of treatments that can change the pace of ALS for some people, ease symptoms for most people, and replace guesswork with a clear plan.

You’ll see what current medicine can and can’t do, where the strongest evidence sits, and how to spot claims that don’t hold up.

What A Cure Would Mean For ALS

People use “cure” in different ways. In ALS, a true cure would do three things at once: stop the disease process, prevent new nerve damage, and restore function so strength and breathing improve back toward prior levels.

Most current treatments aim to slow progression. Think “gentler slope” rather than “full stop.” A gentler slope can mean extra time walking, speaking clearly, swallowing safely, or breathing with less assistance.

Can ALS Be Cured Or Stopped With Today’s Treatments

No therapy has been shown to halt ALS for the broad ALS population or reverse it in a reliable way. The National Institute of Neurological Disorders and Stroke states there is no cure and no effective treatment to halt or reverse progression, while also outlining available care and ongoing research. NINDS information on ALS is a solid official overview.

“No cure” also doesn’t mean “nothing helps.” Many people do best with a layered plan: an ALS-focused clinic, symptom-targeted therapies, breathing and nutrition planning, and the right assistive tech at the right time.

Why Some Headlines Feel Ahead Of The Evidence

News about a compound working in mice or shifting a biomarker can be real progress. It still isn’t the same as restoring function for a wide range of people. A good reality check is simple: who did it help, what was measured, and how long did the effect last?

Medicines That Aim To Slow Progression

In the United States, several drugs are approved to treat ALS or a defined genetic subtype. Some products are different brand forms of the same active ingredient. These drugs don’t fit every person, and effects can be subtle. Matching a drug to your stage, lab profile, and goals matters.

Riluzole

Riluzole has a long track record and is linked to a modest survival benefit across studies. It’s often started early. Liver blood tests are commonly used to track for side effects.

Edaravone

Edaravone is offered as an infusion and as an oral formulation, depending on the product. Trial data suggested benefit in a selected group, often earlier in the disease course and meeting functional criteria. Some clinics still use it beyond that, based on individual tolerance and goals.

Tofersen For SOD1-Related ALS

A smaller subset of ALS is linked to a mutation in the SOD1 gene. For that group, tofersen (Qalsody) is FDA-approved and targets the genetic driver by reducing production of the SOD1 protein. FDA approval for Qalsody summarizes who it is for and how the approval was made.

A Note On Relyvrio

Relyvrio (AMX0035) was previously available in the U.S. and Canada. After a Phase 3 trial did not meet its endpoints, the company announced a process to remove it from the market and stop availability for new patients, with access details described for people already on therapy at that time. Amylyx announcement on RELYVRIO/ALBRIOZA removal lays out the timeline and rationale.

Table: Treatment Options And What They’re Used For

Option	What It Targets	What People Often Notice
ALS clinic with multidisciplinary visits	Coordinated care across neurology, respiratory, nutrition, rehab, speech, and equipment	Fewer gaps, faster equipment timing, clearer planning
Riluzole	Slows progression for many people	Benefit is subtle; lab monitoring may be used
Edaravone	Selected trial populations; oxidative stress pathways	Some people maintain function longer; regimen burden varies
Tofersen (Qalsody) for SOD1 ALS	Genetic-targeted therapy for a defined subtype	Effects can vary by person and timing
Noninvasive ventilation (BiPAP-style)	Breathing muscle weakness and sleep-related hypoventilation	Better sleep and stamina for many
Feeding tube (PEG or similar)	Swallowing fatigue, weight loss, dehydration risk	Easier calories, fluids, and meds with less meal-time strain
Communication tools (voice banking, AAC)	Speech clarity loss and fatigue	Clearer conversations with less frustration
Targeted symptom medicines	Cramps, saliva, sleep, mood, pain	More comfortable daily routines

Breathing And Nutrition: Where Planning Pays Off

Breathing and swallowing changes can drain energy and raise medical risk. When these are tracked early, people often avoid crisis-level drops.

Breathing Monitoring And Noninvasive Ventilation

Breathing weakness can show up as waking headaches, frequent waking, daytime sleepiness, or shortness of breath when lying flat. Clinics often track breathing strength with spirometry and, at times, nighttime measurements.

Noninvasive ventilation can reduce the work of breathing at night. Many people notice better sleep first, then steadier daytime energy. Starting before an emergency tends to make the adjustment easier.

Swallowing, Weight, And Feeding Tubes

Swallowing changes can mean slow meals, coughing with liquids, or fatigue halfway through a plate. Weight can drop even with steady eating, since calorie needs may rise and meals take more work.

A feeding tube can help maintain calories, hydration, and medication delivery. Many people still eat by mouth when it’s safe and enjoyable. Timing is personal, yet planning before breathing weakness is advanced can make the procedure safer.

Rehab, Equipment, And Communication

Rehab in ALS is often about staying mobile and comfortable, preventing painful tightening, and saving energy for the parts of the day that matter most.

Physical And Occupational Therapy

Therapists can suggest stretches, braces, and mobility tools that reduce fall risk and pain. They can also rework home setups: bathroom safety, transfers, ramps, and wheelchair seating.

Speech Therapy And Communication Planning

Speech changes can begin as slurring when tired or a softer voice by evening. Early planning gives you options. Voice banking records phrases while speech is still clear, and AAC tools can step in later.

Clinical Trials And Genetic Testing

Trials are where new treatments prove themselves. Some trials test medicines; others test devices or care approaches. Many ALS clinics can screen you for trials that match your symptom duration, breathing status, and medication history.

Genetic testing can matter even with no family history. Knowing gene status may open trial options or, for a small group, a targeted therapy path such as tofersen for SOD1 ALS.

Red Flags For Claims That Don’t Hold Up

Be cautious with any product or program that:

• Claims to cure ALS without published human trial data.
• Uses testimonials as the main proof.
• Requires large upfront payments or “secret protocols.”
• Frames standard neurology care as a conspiracy story.

Table: Symptoms, Practical Tools, And What To Ask About

Common Issue	Practical Tools	Clinic Questions
Muscle cramps and spasticity	Stretching plan, hydration routines, symptom medicines	“Which options fit my current meds and labs?”
Excess saliva or thick mucus	Portable suction, humidification, targeted medicines	“Can we balance dryness with comfort?”
Fatigue	Energy pacing, mobility aids, breathing checks	“Could sleep breathing be part of this?”
Speech strain	Voice banking, AAC options, amplification	“When should we start device paperwork?”
Swallowing effort	Texture tweaks, nutrition shakes, tube planning	“What timing is safest given my breathing tests?”
Breathlessness	Noninvasive ventilation, cough-assist devices	“Which numbers on my tests trigger changes?”
Mood changes or emotional lability	Targeted medicines, therapy if desired, caregiver planning	“Is this pseudobulbar affect, depression, or both?”

What You Can Do Next: A Practical Appointment Checklist

Bring this list to your next visit and mark what applies.

• Ask for an ALS clinic plan: who you’ll see, how often, and how equipment orders happen.
• Review disease-modifying medicines: what fits your type of ALS, timing, and labs.
• Request baseline breathing numbers: spirometry results and any nighttime testing your clinic uses.
• Set a nutrition target: weight goal, calorie range, and when to revisit tube timing.
• Start communication planning early: voice banking and AAC paperwork can take time.
• Ask about trial screening: what’s available locally and what criteria apply.
• Pick one home safety fix: a grab bar, a shower chair, or a fall-risk walkthrough.

ALS is a hard diagnosis. Still, day-to-day life can shift when care is proactive, measured, and personalized. The goal is steady progress on decisions, not perfection.